semaglutide may 2025 fda shortage status january As of February 21, 2025, the updated its drug list Now that shortages of semaglutide

To maintain a balanced and efficient immune response to infections and foreign invaders, it helps regulate immune cell proliferation, differentiation, and function

Baluchnejadmojarad, R

Furthermore, in obese individuals with sleep disorders, the secretion and activity of GLP-1 RA are decreased, which can lead to abnormal sugar metabolism and weight gain, thereby exacerbating OSA [63, 77, 78]

A 2026 systematic review and meta-analysis of randomized controlled trials confirmed that GLP-1 receptor agonists produce clinically meaningful weight loss across diverse patient populations (Ahmad et al., 2026, PMID: 41824845)

Free initial consultations are available only with select providers

This change also reflects potential considerations regarding tolerability, clinical outcomes, and affordability